Review: Rethinking Medications
- Jan 23, 2025
- 1 min read
From Publishers Weekly
A damning survey of the drug development system’s many failures, this enlightens even as it infuriates.
In this troubling report, Avorn (Powerful Medicines), a professor of medicine at Harvard Medical School, explores problems with the development and administration of medicine. Charting America’s history of underregulating drugs, Avorn notes that listing a medication’s contents on its container only became mandatory in 1906, and that a 1962 law marked the first time pharmaceutical manufacturers had to prove to the Food and Drug Administration that a medication works before bringing it to market.